Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.

Legro RS, Roller RL, Dodson WC, Stetter CM, Kunselman AR, Dunaif A.

J Clin Endocrinol Metab. 2010 Feb;95(2):789-99. doi: 10.1210/jc.2009-1849. Epub 2009 Dec 4.

2.
3.

Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.

Mumm H, Jensen DM, Sørensen JA, Andersen LL, Ravn P, Andersen M, Glintborg D.

Acta Obstet Gynecol Scand. 2015 Feb;94(2):204-11. doi: 10.1111/aogs.12545. Epub 2014 Dec 25.

PMID:
25417943
4.

Singleton birthweight by gestational age following in vitro fertilization in the United States.

Dickey RP, Xiong X, Pridjian G, Klempel MC.

Am J Obstet Gynecol. 2016 Jan;214(1):101.e1-101.e13. doi: 10.1016/j.ajog.2015.08.008. Epub 2015 Aug 8.

PMID:
26264826
5.

A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.

De Frène V, Vansteelandt S, T'Sjoen G, Gerris J, Somers S, Vercruysse L, De Sutter P.

Hum Reprod. 2014 Oct 10;29(10):2333-8. doi: 10.1093/humrep/deu154. Epub 2014 Jun 24.

PMID:
24963163
6.

Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.

Jones MR, Mathur R, Cui J, Guo X, Azziz R, Goodarzi MO.

J Clin Endocrinol Metab. 2009 Dec;94(12):5034-8. doi: 10.1210/jc.2009-0931. Epub 2009 Oct 16.

7.

Birthweight percentiles by gestational age for births following assisted reproductive technology in Australia and New Zealand, 2002-2010.

Li Z, Wang YA, Ledger W, Sullivan EA.

Hum Reprod. 2014 Aug;29(8):1787-800. doi: 10.1093/humrep/deu120. Epub 2014 Jun 7.

PMID:
24908671
8.

Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.

Fulghesu AM, Manca R, Loi S, Fruzzetti F.

Fertil Steril. 2015 Mar;103(3):808-14. doi: 10.1016/j.fertnstert.2014.12.109. Epub 2015 Jan 27.

PMID:
25637475
9.

Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.

Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A.

J Clin Endocrinol Metab. 2010 May;95(5):2180-6. doi: 10.1210/jc.2009-2651. Epub 2010 Mar 12.

10.

Prenatal famine, birthweight, reproductive performance and age at menopause: the Dutch hunger winter families study.

Yarde F, Broekmans FJ, van der Pal-de Bruin KM, Schönbeck Y, te Velde ER, Stein AD, Lumey LH.

Hum Reprod. 2013 Dec;28(12):3328-36. doi: 10.1093/humrep/det331. Epub 2013 Aug 21.

11.

High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.

Coviello AD, Sam S, Legro RS, Dunaif A.

J Clin Endocrinol Metab. 2009 Nov;94(11):4361-6. doi: 10.1210/jc.2009-1333. Epub 2009 Oct 16.

12.

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.

Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD.

Am J Obstet Gynecol. 2008 Jun;198(6):670.e1-7; discussion 670.e7-10. doi: 10.1016/j.ajog.2008.01.037. Epub 2008 Mar 20.

PMID:
18355776
13.

Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.

Gambineri A, Patton L, De Iasio R, Palladoro F, Pagotto U, Pasquali R.

J Clin Endocrinol Metab. 2007 Jun;92(6):2066-73. Epub 2007 Mar 13.

PMID:
17356050
14.

Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).

Ashrafi M, Sheikhan F, Arabipoor A, Hosseini R, Nourbakhsh F, Zolfaghari Z.

Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:195-9. doi: 10.1016/j.ejogrb.2014.07.043. Epub 2014 Aug 7.

PMID:
25150960
15.

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.

Glueck CJ, Bornovali S, Pranikoff J, Goldenberg N, Dharashivkar S, Wang P.

Diabet Med. 2004 Aug;21(8):829-36.

PMID:
15270785
16.

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.

Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A.

Fertil Steril. 2007 Nov;88(5):1389-95. Epub 2007 Apr 26.

PMID:
17462641
17.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE).; American College of Endocrinology (ACE).; Androgen Excess and PCOS Society..

Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Review.

PMID:
26642102
18.

Australian national birthweight percentiles by sex and gestational age, 1998-2007.

Dobbins TA, Sullivan EA, Roberts CL, Simpson JM.

Med J Aust. 2012 Sep 3;197(5):291-4. Erratum in: Med J Aust. 2013 Mar 4;198(4):189.

PMID:
22938128
19.

Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study.

Løvvik TS, Wikström AK, Neovius M, Stephansson O, Roos N, Vanky E.

BJOG. 2015 Sep;122(10):1295-302. doi: 10.1111/1471-0528.13339. Epub 2015 Mar 11.

20.

Phenotype and genotype in polycystic ovary syndrome.

Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF 3rd, Dunaif A.

Recent Prog Horm Res. 1998;53:217-56. Review.

PMID:
9769710

Supplemental Content

Support Center